Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP883713.RAyweoO5SYVzeYFAxDst-DWb4WwI1LyzwFpKxl7DrFYTw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP883713.RAyweoO5SYVzeYFAxDst-DWb4WwI1LyzwFpKxl7DrFYTw130_assertion type Assertion NP883713.RAyweoO5SYVzeYFAxDst-DWb4WwI1LyzwFpKxl7DrFYTw130_head.
- NP883713.RAyweoO5SYVzeYFAxDst-DWb4WwI1LyzwFpKxl7DrFYTw130_assertion description "[Taken together, these results identify LATS1 and LATS2 as novel HSP90 clients and show that HSP90 inhibitors can disrupt the LATS tumor suppressor pathway in human cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP883713.RAyweoO5SYVzeYFAxDst-DWb4WwI1LyzwFpKxl7DrFYTw130_provenance.
- NP883713.RAyweoO5SYVzeYFAxDst-DWb4WwI1LyzwFpKxl7DrFYTw130_assertion evidence source_evidence_literature NP883713.RAyweoO5SYVzeYFAxDst-DWb4WwI1LyzwFpKxl7DrFYTw130_provenance.
- NP883713.RAyweoO5SYVzeYFAxDst-DWb4WwI1LyzwFpKxl7DrFYTw130_assertion SIO_000772 20841485 NP883713.RAyweoO5SYVzeYFAxDst-DWb4WwI1LyzwFpKxl7DrFYTw130_provenance.
- NP883713.RAyweoO5SYVzeYFAxDst-DWb4WwI1LyzwFpKxl7DrFYTw130_assertion wasDerivedFrom befree-20150227 NP883713.RAyweoO5SYVzeYFAxDst-DWb4WwI1LyzwFpKxl7DrFYTw130_provenance.
- NP883713.RAyweoO5SYVzeYFAxDst-DWb4WwI1LyzwFpKxl7DrFYTw130_assertion wasGeneratedBy ECO_0000203 NP883713.RAyweoO5SYVzeYFAxDst-DWb4WwI1LyzwFpKxl7DrFYTw130_provenance.